Scheer Medical PLC
Seymour
About Scheer Medical PLC
Cereplast develops and commercializes bio-based resins. It provides Cereplast compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications. The company also offers Cereplast Sustainables resins, including Cereplast Hybrid resins that replace up to 55% of the petroleum content in conventional plastics with bio-based materials, such as industrial starches sourced from plants that are used in automotive, consumer goods, consumer electronics, medical, packaging, and construction markets; and Cereplast Algae Plastic resins, which transforms algae into bioplastics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $25.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2012)
- Ticker: otcpink:CERPQ
- Website: cereplast.com
- Phone: (812)524-2373
Industries & Categories
Manufacturing, Product Design, Sustainability
Social Profiles
Canonical: https://fsome.com/organization/scheer-medical-plc-1241223 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.